Cramer: Gilead Is Dead Money

Loading...
Loading...

Jim Cramer said on CNBC's "Mad Money" that Gilead Sciences, Inc. GILD is "dead money." He can't think of a reason to buy it. Cramer thinks that selling at $67 "seems wrong," but he sees no catalyst to buy it.

Las Vegas Sands Corp. LVS is a good company, said Cramer. He advised his viewer to hold the stock. It's trading at its 52-week high, but Cramer is a buyer at the current price level.

Related Links:

Benzinga's Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time

Gilead Sciences Q1 2018 Financial Results

Posted In: MediaCNBCJim CramerMad Money
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...